Algenis
PrivateLast Round
VC Round
Oct 6, 2011
Company Overview
Algenis operates in Healthcare & Life Sciences and is based in Santiago. Its latest recorded funding round was a VC Round in October 2011.
Algenis is a biotechnology company that specializes in the research, production, and clinical development of bioactive molecules derived from marine microalgae for therapeutic use.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Algenis Comparables
Compare Algenis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlgavitaBio, Inc. | 80% | |
| Dogwood Therapeutics, Inc. | 74% | |
| Sirenas Marine Discovery | 70% |
For institutional investors. Book with your work email.
Algenis Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Algenis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aurus Capital | VC Round |
Algenis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Algenis's valuation, stock price, and market status.
Is Algenis a public or private company?
Algenis is a private company.
What is the current stock price of Algenis?
Algenis is a private company, so its shares have no public market price. Caplight tracks Algenis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Algenis worth (valuation)?
Valuation information for Algenis is not publicly available.
Can I buy Algenis stock?
Algenis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Algenis's last funding round?
Algenis's most recent funding round was VC Round on October 6, 2011.
Who are the main investors in Algenis?
Key investors in Algenis include Aurus Capital.
Will Algenis IPO soon?
No public IPO plans have been announced for Algenis.
How can I track Algenis secondary market activity?
Caplight tracks bids, offers, and trades in Algenis's shares on secondary markets.